?fibrinogen

fibrinogen 發(fā)音

英：[fa??br?n?d??n?f??br?n?d??n]　　美：[fa??br?n?d??n; f??br?n?d??n]

英：　　美：

fibrinogen 中文意思翻譯

fibrinogen 詞性/詞形變化，fibrinogen變形

形容詞: fibrinogenous |

fibrinogen 短語(yǔ)詞組

1、fibrinogen tests ─── [醫] 纖維蛋白原試驗(檢肝機能)

fibrinogen 相似詞語(yǔ)短語(yǔ)

1、fibrinogenous ─── 纖維蛋白原

2、fibrino- ─── 纖維

3、fibrinous ─── adj.纖維蛋白的

4、fibrinolysins ─── n.溶纖維蛋白酵素

5、fibrinogenic ─── adj.纖維蛋白原的，產(chǎn)生纖維蛋白的

6、fibrinolysin ─── n.溶纖維蛋白酵素

7、fibrinoid ─── adj.纖維蛋白樣的；n.類(lèi)纖維蛋白

8、ferricyanogen ─── 鐵氰化物

9、fibrinogenically ─── 纖維蛋白原

fibrinogen 常見(jiàn)例句（雙語(yǔ)使用場(chǎng)景）

1、White blood cells, platelets, fibrinogen, and coagulation factors were decreased during the early stage of plasma separation and appeared to be ... ─── 白細胞、血小板和四種凝血因子在分離開(kāi)始時(shí)都有不同程度地減少,但均在臨床允許的范圍內。

2、Results:The abnormal hemorheology was improved,and fibrinogen was decrease after treatment. ─── 用血塞通治療后血液流變學(xué)各指標有顯著(zhù)性改善,血液纖維蛋白原含量降低。

3、Relationship between Serum Advanced Fibrinogen and Activity of Blood Platelet Membrane Glycoprotein Receptor ─── 冠心病患者纖維蛋白原濃度與血小板膜糖蛋白受體活性表達

4、a rare congenital disorder of blood coagulation in which no fibrinogen is found in the blood plasma ─── 一種罕見(jiàn)的先天性血液凝固混亂癥

5、The transcription protein of down-regulated genes related to degradation of fibrinogen, and to production of protooncogene. ─── 在表達下調的基因中其轉錄產(chǎn)物涉及纖維蛋白原的降解、原癌基因產(chǎn)物的生成等。

6、Keywords non-valvular atrial fibrillation;fibrinogen;D-dimer;left atrium; ─── 心房纖顫;纖維蛋白原;D-二聚體;左心房;

7、Results Blood viscosity, hematocrit and fibrinogen were remarkably decreased after gastric lavage. ─── 結果洗胃后血液流變學(xué)多項指標顯著(zhù)下降，紅細胞剛性明顯升高。

8、Methods The levers of plasma fibrinogen and hematocrit were measured in 30 normal subjects 60 diabetics without microangiopathy and 64 diabetics with microangiopathy. ─── 方法按統一要求測定124例糖尿病患者及30例正常人的血漿纖維蛋白原和紅細胞比積。

9、Plasma fibrinogen was measured in 82 healthy persons, 46 patients with coronary heart disease(CHD) uiagnosed by coronary arteriography, and 15 patients with acute myocardial infarction(AMI). ─── 本文測定正常人82名、經(jīng)冠狀動(dòng)脈造影診斷的冠心病(CHD)患者46例、急性心肌梗塞(AMI)患者15例的血漿纖維蛋白原含量。

10、Keywords Hyperlipidemia;C reactive protein;Fibrinogen;Antilipemic agents; ─── 關(guān)鍵詞高脂血癥;C-反應蛋白;纖維蛋白原;調血脂藥;

11、ADSORPTION OF FIBRINOGEN ON THE SURFACES OF BIOMATERIALS STUDIED BY USING SURFACE PLASMON RESONANCE (SPR) SENSOR ─── 用SPR生物傳感器研究纖維蛋白原在生物醫用材料表面的吸附

12、a rare congenital disorder of blood coagulation in which no fibrinogen is found in the blood plasma. ─── 一種罕見(jiàn)的先天性血液凝固混亂癥。

13、Detection of staphylococcal clumping factor with purified fibrinogen ─── 用純化纖維蛋白原檢測葡萄球菌凝聚因子

14、Methods: Platelet aggregation was measured by turbidimetry,adhesion was indicated by platelet retention rate obtained from spinning glass bottle and fibrinogen was analysed by colorimetry. ─── 方法： 比濁法觀(guān)察血小板聚集功能，玻瓶法觀(guān)察血小板粘附功能，小鼠剪尾法觀(guān)察出血時(shí)間，比色法測定纖維蛋白原含量。

15、low molecular weight fibrinogen degradation products ─── 低分子量纖維蛋白原降解產(chǎn)物

16、Infant can incorporate thrombocytopenic purpura and fibrinogen deficiency, cause fatal haemorrhage, hemolysis. ─── 嬰幼兒可合并血小板減少性紫癜及纖維蛋白原缺乏癥，引起致命的出血、溶血。

17、Method: According to inspecting the whole blood low specific viscosity,the index of aggregation of RBC,ESR,fibrinogen,TG and HBA_ 1c on DE,DM and NS. ─── 方法 :分別對糖尿腸病組 (DE)、糖尿病組 (DM )、健康人組 (NS)進(jìn)行了低切變率下全血粘度、紅細胞聚集指數、血沉、纖維蛋白原、甘油三酯及糖化血紅蛋白指數的檢測。

18、The serum fibrinogen level was decreased significantly in the treatment group. ─── 治療組血纖維蛋白原水平降低顯著(zhù)，不良反應輕微。

19、Method: Make a comparison of hemorheological index,fibrinogen as well as the number of platelets between 98 elder patients with malignant tumors and 40 healthy counterparts. ─── 方法:對98例老年惡性腫瘤患者及40例健康老年人血液流變學(xué)指標、血小板計數、纖維蛋白原指標進(jìn)行比較。

20、The Change of Serum Lipoprotein and Fibrinogen in Patients with Different Degree of Coronary Artery Stricture ─── 冠狀動(dòng)脈不同程度狹窄時(shí)血脂載脂蛋白和纖維蛋白原變化

21、freeze-dried human fibrinogen ─── 干燥人纖維蛋白原

22、Methods 60 cases of ischemic cerebrovascular disorder(both acute and decubation)and 20 normal controls were tested for plasma fibrinogen,and the results were analyzed. ─── 方法檢測60例缺血性腦卒中患者(急性期和恢復期)及20名正常對照者血漿中纖維蛋白原濃度,進(jìn)行比較分析。

23、Keywords Coronary heart disease;Fibrinogen;Relativity; ─── 冠心病;纖維蛋白原;相關(guān)性;

24、Relationship between plasma fibrinogen and cardiovascular risk factors in apparently healthy Chinese subjects ─── 健康人群血漿纖維蛋白原與心血管危險因素的關(guān)系

25、radioactive fibrinogen uptake test ─── 放射性纖維蛋白原攝取試驗

26、Methods To measure plasma prothrombin time (PT), activate part plasma prothrombin time (APTT), prothrombin time (TT) and fibrinogen(FIB) in 49 cases type 2 diabetics and 30 cases normal controls. ─── 方法利用全自動(dòng)血凝儀檢測30例正常健康體檢者及49例2型糖尿病患者的PT、APTT、TT及FIB值。

27、NMR-active fibrinogen derivative ─── 核磁共振活性纖維蛋白原衍生物

28、Three skin biopsies demonstrated degeneration of fibrinogen, perivenous infiltration of inflammatory cells. ─── 皮膚活檢3例示膠原變性，小靜脈周?chē)梢?jiàn)炎性細胞浸潤。

29、If another fetal continue to grow growth is good, level of fibrinogen of pregnant mother plasma is stable, can continue to observe. ─── 倘若另一胎兒繼續生長(cháng)發(fā)育良好，孕母血漿纖維蛋白原水平穩定，可以繼續觀(guān)察。

30、PRITHROMBIN TIME DERIVED FIBRINOGEN DETERMINATION ON SYSMEX CA-1500. ─── pt衍生法測定纖維蛋白原在CA1500上的應用

31、APTT, ELT and fibrinogen were determined. ─── 同時(shí)測定APTT、ELT和血漿纖維蛋白原的含量。

32、the hydrolization of fibrinogen or plasminogen; ─── 二是水解血纖維蛋白或纖溶酶原;

33、Antibody coated bacteria(ACB),lysozyme(Lys)and fibrinogen degradation pro- ─── 對220例尿路感染作尿抗體包裹細菌(ACB)溶菌酶(Lys)及纖維蛋白降解產(chǎn)物(FDP)檢查的結果,表明Lys 與ACB 及FDP 與ACB 符合率分別為77.7%和76.5%。

34、Keywords hirudin;fibrinogen;thrombin;determination of activity; ─── 水蛭素;纖維蛋白原;凝血酶;活性測定;

35、Prothrombin time (PT), international normalized ratio (INR), partially activated thromboplastin time (APTT) and fibrinogen (FIB) were detected. ─── 檢測凝血酶原時(shí)間(PT)、凝血酶原時(shí)間國際標準化指數(INR)、部分活化凝血酶原時(shí)間(APTT)和纖維蛋白原濃度(FIB)。

36、They also measured blood leels of the inflammatory markers interleukin (IL)-6, C-reactie protein (CRP), and fibrinogen. ─── 他們也檢測了炎癥標記物白介素-6、C-反應蛋白和纖維蛋白原的血漿水平。

37、Methods According to ICSH and NCCLS documents,precision,accuracy,carryover pollution rate and anti-interference of prothrombin time,activated partial prothrombin time,thronbin time and fibrinogen on the instrument were examined. ─── 方法 參照 ICSH和 NCCLS有關(guān)文獻對該儀器所檢測的凝血酶原時(shí)間、活化部分凝血酶原時(shí)間、凝血酶時(shí)間及纖維蛋白原等項目作了精密度、準確性、交叉污染率和抗干擾能力測試。

38、Methods: The changing of platelet aggregation rate, the thrombus weight, the content of fibrinogen and the euglobulin lysis time were determined after SEF iv on rabbit and mice. ─── 方法:采用全蝎提取液給家兔、小鼠靜脈注射,并測定其血小板最大聚集率、血栓重量、纖維蛋白原含量及優(yōu)球蛋白溶解時(shí)間的變化。

39、In the diabetic patients, the plasma levels of TM were positively correlated with fasting plasma glucose(FPG), blood urea nitroge(BUN), creatinine(Cr), fibrinogen(FIB),urine microalbumin(UMA) and diabetic refinopathy(DR). ─── TM與空腹血糖(FPG)、血尿素氮(BUN)、肌酐(Cr)、纖維蛋白原(FIB)、尿微量白蛋白(UMA)、糖尿病視網(wǎng)膜病變(DR)呈正相關(guān);

40、Method ESR, hematocrit and plasma fibrinogen level of 445 middle age and elder male and female individuals were examined and dynamic ESR analysis to all subjects was performed. ─── 方法對445例無(wú)活動(dòng)性炎癥的男女性中老年成人檢測ESR-K、血漿纖維蛋白原及紅細胞壓積，并作動(dòng)態(tài)ESR分析。

41、Methods The blood pressure,blood glucose,blood lipid(cholesterol,glyceryltrioleate)and fibrinogen of 60 cases of PS were analyzed retrospectively and treated with statistics. ─── 方法回顧性分析了60例進(jìn)展性腦梗死患者的血壓、血糖、血脂及纖維蛋白原指標,并進(jìn)行統計學(xué)處理。

42、Changes of rheoencephalogram,blood rheology and fibrinogen were observed before and after the treatments and clinical improvements for two therapies were evaluat-ed. ─── 然后，對63例病人聯(lián)合用藥，同樣在治療前、后做腦血流圖、血流變學(xué)和纖維蛋白原檢查進(jìn)行分析，最后對兩組病人進(jìn)行臨床療效的對比分析。

43、Fibrinogen and cruor zymogen time should be checked before cure, under normal person unfavorable application. ─── 治療前應檢查纖維蛋白原及凝血酶原時(shí)間，低于正常者不宜應用。

44、The improvement extent of high spear of whole blood viscosity, plasma viscosity, fibrinogen, time value ... ─── 另外,觀(guān)察中發(fā)現,兩組臨床癥狀、體征均有一定改善,治療組優(yōu)于對照組。

45、Keywords Fibrinogen;Clauss method;Thermal turbidimetry; ─── 關(guān)鍵詞纖維蛋白原;克勞斯法;熱濁度法;

46、Abstract Purpose: To study the effects of glycol mannate sulfate(GMS) on platelet aggregation and adhesion,bleeding time and fibrinogen. ─── 摘 要 目的： 研究單甘酯對血小板聚集、粘附功能及出血時(shí)間和纖維蛋白原含量的影響。

47、Keywords unstable angina pectoris;fibrinolysin;fibrinogen; ─── 心絞痛;不穩定型;纖溶酶;纖維蛋白原;

48、Keywords Raman spectroscopy;gastritis;gastric ulcer;Fibrinogen;Spermine; ─── 拉曼光譜;精胺;纖維蛋白原;胃炎;胃潰瘍;

49、They also have lower counts of fibrinogen, an essential blood clotting protein that in high does in an indicator of future heart disease. ─── 他們也相應地維持較低的纖維蛋白原數量，那是一種已顯示出，因為其數量居高而會(huì )產(chǎn)生將來(lái)心臟疾病的重要的血液凝固蛋白質(zhì)。

50、Keywords Intimal proliferation;Vascular remodeling;Angioplasty;Verapamil;Plasma fibrinogen; ─── 再狹窄;血管成形術(shù);纖維蛋白原;維拉帕米;

51、Correlation of degree of coronary artery pathologic change with fibrinogen in CHD patients ─── 冠心病患者血漿纖維蛋白原與冠狀動(dòng)脈病變程度的相關(guān)性研究

52、Since fibrinogen is derived from human body, the physician must evaluate the risk that serum hepatitis may follow its use. ─── 由于“纖維蛋白原”來(lái)自人血，醫生必須估計到使用本品后可能引起血清肝炎的危險性。

53、Poisoning by human fibrinogen ─── 人纖維蛋白原中毒

54、The plasma fibrin D-dimer was measured using enzyme linked immunoassay. Fibrinogen(Fg) and hs-CRP were measured. ─── 用酶聯(lián)免疫吸附法測定血漿D-二聚體、用全自動(dòng)血凝分析儀測定血漿Fg、用免疫濁度法測定hs-CRP。

55、For detecting the process of reaction between Bromelain and Fibrinogen, quantum dots synthesized in aqueous solution were used to label bromelain in order to form CdTe-Bromelain. ─── 用量子點(diǎn)標記菠蘿蛋白酶,以此為熒光探針,監測其與纖維蛋白原的反應過(guò)程.實(shí)驗結果表明,隨著(zhù)反應時(shí)間的增加,熒光光譜逐漸藍移,熒光強度也逐漸下降

56、Objective: Study of plasma fibrinogen level and function on pregnancy women. ─── 目的：研究妊娠期婦女血漿纖維蛋白原的水平與功能。

57、Methods Activities of tissue type plasminogen activator(t PA) and plasminogen activator inhibitor(PAI) and contents of D dimeter(D D) and fibrinogen(FbG) were determined in 22 patients with TIA and compared with 22 normal controls. ─── 方法 對 2 2例頸內動(dòng)脈系統TIA患者血漿組織型纖溶酶原激活物 (t PA)及其快速抑制物 (PAI)的活性、D 二聚體 (D D)及纖維蛋白原 (FbG)含量進(jìn)行檢測 ,并與對照組進(jìn)行比較。

58、Objective To explore the influence of concentrations of common antibiotics on the fibrinogen in plasma. ─── 摘要目的研究4種常用抗菌素的濃度對血漿纖維蛋白原的影響。

59、Conclusion The high levels of fibrinogen are one of the risk factors in acute progressive cerebral infarction. ─── 結論發(fā)病后高纖維蛋白原水平為急性進(jìn)展性腦梗死的危險因素。

60、Meanwhile, the patients" blood sugar blood fat HbAlc fibrinogen abated obviously, the difference was significant compared to the control group (P

61、Methods Add the cefoperazone sodium, chloromycetin, ciprofloxacin lactate and gentamycin sulfate at different concentrations into plasma and determine the coagulation time and content of fibrinogen. ─── 方法采用凝固法，以加入抗菌素后血漿中纖維蛋白原的凝固時(shí)間為指標，觀(guān)察不同濃度的頭孢哌酮鈉、氯霉素、乳酸環(huán)丙沙星和硫酸慶大霉素對血漿纖維蛋白原的影響。

62、Intima-injury model was made. On fibrinogen and collagen,platelet adhesion on area of experimental group was lower than that in negative control group(P

63、The increased levels of fibrinogen and homocysteine seen in relation to secondhand smoke exposure were equivalent to 30% to 45% of those seen for active smoking. ─── 與二手煙有關(guān)的纖維素原和同型半胱氨酸水平增加約等于這兩個(gè)生物標記物在吸煙時(shí)水平的30%到50%。

64、Methods: 50 patients with TIA and 50 controls from the health were performed overnight polysomnography as well as blood routine, lipidemia, blood viscosity and fibrinogen. ─── 方法對TIA患者和健康對照組各50例進(jìn)行整夜多導睡眠檢測，以及血常規、血脂、血黏度、纖維蛋白原檢測。

65、Cryodesiccant Human Fibrinogen ─── 凍干人纖維蛋白原, 人血纖維蛋白原, 纖維蛋白原[促凝血藥]

66、Objective To observe the effect of hyperbaric oxygen(HBO) on D-dimer(D-D) and fibrinogen(Fg) in the blood plasma of ischemic apoplexy patients. ─── 作者單位：南京醫科大學(xué)附屬常州第二人民醫院高壓氧科;

67、Clinical significance of blood platelet count and serum fibrinogen in patients with ovarian carcinoma ─── 卵巢惡性腫瘤患者血漿纖維蛋白原及血小板四項參數檢測的臨床意義

68、When the cruor inside blood-vessel of chronic dispersion sex, but because use up with generate achieve dynamic balance and the fibrinogen drops not apparent. ─── 慢性彌散性血管內凝血時(shí)，可因消耗與生成達到動(dòng)態(tài)平衡而纖維蛋白原下降不明顯。

69、In spite of the relatively small number of patients, the clinical results are relevant because they were confirmed by the results of the fibrinogen test. ─── 盡管受試患者的數量相對較少，該臨床研究的結論是可信的，因為其結論通過(guò)纖維蛋白原測試得到了進(jìn)一步論證。

70、Fibrinogen and Albumin Levels and Risk of Atrial Fibrillation in Men and Women(the Copenhagen City Heart Study) ─── 男性和女性房顫發(fā)生風(fēng)險與纖維蛋白原及白蛋白水平的關(guān)系:哥本哈根市心臟研究

71、The concentrations of cefoperazone sodium, chloromycetin, ciprofloxacin lactate and gentamycin sulfate showed significant influence on the coagulation time and detection rate of fibrinogen in plasma. ─── 頭孢哌酮鈉、氯霉素、乳酸環(huán)丙沙星、硫酸慶大霉素等抗菌素及其濃度變化對血漿中纖維蛋白原的凝固時(shí)間和檢出率有顯著(zhù)影響。

72、The RBC's here have stacked together in long chains.This is known as "rouleaux formation" and it happens with increased serum proteins, particularly fibrinogen and globulins. ─── RBC成疊連狀，稱(chēng)為“緡錢(qián)壯紅細胞”，當血清蛋白質(zhì)，特別是纖維蛋白原和球蛋白增加時(shí)出現。

73、Influence Exerted by Qinggong Zhixue Granule on The Content of Rabbits'Fibrinogen and Mice's Mesentery Microcirculation ─── 清宮止血顆粒對家兔纖維蛋白原含量與小鼠腸系膜微循環(huán)的影響

74、Study of serum C-reactive protein or fibrinogen and coronary lesions in patients with unstable angina pectoris ─── 不穩定型心絞痛患者冠脈血管病變與血清C-反應蛋白、纖蛋白原的關(guān)系研究

75、There was an acute phase response: fibrinogen levels went up, but there was no organ damage and the animals survived. ─── 發(fā)現有一個(gè)急性期反應：纖維蛋白原水平增高，但沒(méi)有器官損傷，且動(dòng)物都存活。

76、The substance is now more commonly known as fibrinogen, a key protein in the clotting process. ─── 該物質(zhì)現在通常被稱(chēng)為纖維根，是凝血過(guò)程中的關(guān)鍵蛋白質(zhì)。

77、NMR active fibrinogen derivative ─── (核)磁共振活性纖維蛋白原衍生物

78、Objective: To establish one method for determining fibrinogen in plasma by saturated salt solution turbidimetry. ─── 目的：建立一種用飽和鹽水比濁法測定血漿纖維蛋白原的方法。

79、Before and after treamet, levels of mean pulmonary artery pressure (mPAP), plasma endothelin (ET) - 1, fibrinogen(Fg) and D -dirner(D-D) were measured. ─── 測定兩組治療前后平均肺動(dòng)脈壓(mPAP)、血漿內皮素-1(EF-1)、纖維蛋白原(Fg)及D-二聚體(D-D)水平。

80、Objective To observe the effect of Cinepazide Maleate injection (CMI) on hemorheology and fibrinogen in patients with acute cerebral infarction (ACI). ─── 摘要目的觀(guān)察馬來(lái)酸桂哌齊特注射液對急性腦梗死病人血液流變學(xué)指標和纖維蛋白原的影響。

81、Thrombin is an enzyme that catalyzes the conversion of the soluble plasma protein fibrinogen to the insoluble protein fibrin. ─── 凝血酶能催化可溶性血漿纖維蛋白轉化為不溶性的纖維蛋白。

82、The effects of ticlopidine on platelet aggregation(PAg) and plasma fibrinogen(Fg) level were investigated and compared with those of acetylsalicylic acid(ASA) in patients with coronary artery disease(CAD). ─── 本研究對冠心病患者應用噻氯吡啶對血小板聚集功能（plateletaggregation，PAg）及血漿纖維蛋白原（fibrinogen，Fg）水平的影響進(jìn)行探討并與乙酰水楊酸（acetylsalicyliaacid，ASA）進(jìn)行比較。

83、To fibrin therapeutic use extracted from the venom of the anticoagulant effect of a substance, can be reduced fibrinogen and blood viscosity, for the treatment of arteriovenous thrombosis was good results. ─── 去纖維蛋白治療應用從蛇毒中提取的一種抗凝作用的物質(zhì)，可以降低纖維蛋白原和血液粘度，用以治療動(dòng)靜脈血栓獲得良好效果。

84、Their ages, sexes, the levels of lipid, fibrinogen and blood glucose, fever, leukocytosis, mean arterial pressure, diabetes history and signs of early cerebral infarction on CT were compared. ─── 對兩組患者的年齡、性別、血脂水平、血纖維蛋白原水平、血糖水平、發(fā)熱、白細胞增多、平均動(dòng)脈壓、糖尿病史和CT早期梗死征象進(jìn)行比較。

85、Partial correlation analysis showed that plasma fibrinogen was positively correlated with C reactive protein. (r =0.592, P

86、This new polysaccharide derived material enhances the fibrinogen clottability for haemostatic action and becomes hydrogel as a separation barrier after contacting with body liquid for anti-adhesion. ─── 止血防粘連生物紙是一種采用天然多糖交鏈制成的新型可降解止血防粘連材料,具有纖維蛋白原活性增強作用和吸水后呈水凝膠結構起到隔離防粘連作用。

87、Keywords Phospholipase A_2;Coagulant activity;Fibrinogen;Thrombin-like;Serine protease; ─── 凝血活性;纖維蛋白原;類(lèi)凝血酶;絲氨酸蛋白酶;

88、Methods:Anticoagulant activity was determined by measuring prothrombin time(PT),thrombin time(TT),activated partial throboplstin time(APTT) and fibrinogen coagulation time(FCT). ─── 方法:測定水蛭乙醇提取物不同萃取部位對凝血酶原時(shí)間(PT),凝血酶時(shí)間(TT),活化的部分凝血活酶時(shí)間(APTT),纖維蛋白原凝固時(shí)間(FCT)的影響。

89、John Danesh,Lewington,Dphil,et al.lasma Fibrinogen Level and the Risk of Major Cardiovascular Diseases and Nonvascular Mortality[J].JAMA,2005,294,1799. ─── 張劍,韓雅玲,康建,等.纖維蛋白原與冠心病類(lèi)型、危險因素及病變的相關(guān)性[J].心臟雜志,2003,15(2):134.